Work

Phase II study of cabozantinib for patients with advanced RET-rearranged lung cancers.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.8007

Authors: Alexander E. Drilon, Camelia S. Sima, Romel Somwar, Roger Smith, Michelle S. Ginsberg, Gregory J. Riely, Charles M. Rudin, Marc Ladanyi, Mark G. Kris, Naiyer A. Rizvi

Institutions: Memorial Sloan Kettering Cancer Center, Columbia University Irving Medical Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2604216729

Cites:

Cited by: 30

Related to: 10